Skip to main content

Scientist-Candidates Head to Election Day

With a dwindling number of days until elections in the US, Science takes a look at the scientist-candidates still in the race.

In February, the Huffington Post reported that some 60 people with science or technology backgrounds were running for federal-level office, while another 200 were seeking elected positions at state or other levels. It attributed much of this increased political interest by scientists to Trump Administration policies that disregarded science.

By June, only a few of those candidates were still in the running. Science reported then that many scientist-candidates performed poorly in primary races, with some eking out only a small percentage of votes.

But about 18 scientist-candidates are still on the November ballot for the US House of Representatives, Science now reports. Some, it notes, have decent odds of being elected, while others appear to be more long-shot candidates. For instance, it says that Chrissy Houlahan (D-Penn.), an industrial engineer with a master's degree, is favored to win her district, while Rob Davidson (D-Mich.), an emergency room physician, is running against a four-term incumbent.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.